Back to FRANKLIN RESOURCES INC

REGN
Showing 8 of 26 quarters

Position history for FRANKLIN RESOURCES INC's holdings in REGENERON PHARMACEUTICALS

FRANKLIN RESOURCES INC holds 2.7M shares of REGN (REGENERON PHARMACEUTICALS), worth $2.1B as of 2026-Q1. The position was increased (+6.3% shares). REGN represents 0.5% of FRANKLIN RESOURCES INC's portfolio.

Current Value

$2.1B

Current Shares

2.7M

Total Value Change

+$81.9M

Total Shares Change

+798,969

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
2.7M
+6.3%
$2.1B0.5%$766.66
48
2025-Q4
Increased
2.6M
+4.4%
$2B0.5%$773.94
40
2025-Q3
Increased
2.5M
+6.0%
$1.4B0.3%$560.05
41
2025-Q2
Increased
2.3M
+1.6%
$1.2B0.3%$519.56
39
2025-Q1
Increased
2.3M
+11.3%
$1.4B0.4%$634.66
42
2024-Q4
Increased
2M
+7.9%
$1.5B0.4%$698.71
41
2024-Q3
Decreased
1.9M
-1.4%
$1.9B0.5%$1,036.94
0
2024-Q2
Increased
1.9M
+13.5%
$2B0.6%$1,045.23
51

Other major holders of REGN: VANGUARD GROUP INC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used